nach oben

Current Pulmonology Reports

Erschienen in:

14.07.2018 | Lungs Transplant (R Bag, Section Editor)

It's What’s Inside that Counts: Body Composition and Lung Transplantation

verfasst von: Jessica Lau, Erin F. Barreto, Anupam Kumar, Cassie C. Kennedy

Erschienen in: Current Pulmonology Reports | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Factors such as weight, body composition, and functional status appear to influence lung transplant outcomes. Body mass index (BMI) is incorporated into the International Society for Heart and Lung Transplantation’s (ISHLT) recipient selection guidelines. Data suggests BMI does not effectively differentiate patients with high body fat percentage or low lean muscle mass, leading to both over and under estimates of candidates’ risks.

Recent Findings

Recent research has focused on alternate measures and estimates of body composition and their associations with important lung transplant outcomes. Herein, we review the current literature on body composition in lung transplantation, including the variety of measurements used and the concepts of obesity, low muscle mass, and frailty.

Summary

The concept of body composition is evolving beyond the relationship between weight and height as represented by a calculated body mass index. Radiographic assessments and serum markers allow for a more precise and representative measurement of body composition which takes into consideration fat percentage and muscle mass.

Valapour M, Lehr CJ, Skeans MA, Smith JM, Carrico R, Uccellini K, et al. OPTN/SRTR 2016 Annual Data Report: Lung. Am J Transplant. 2018;18:363–433.CrossRefPubMed

Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S, et al. A consensus document for the selection of lung transplant candidates: 2014—an update from the pulmonary transplantation Council of the International Society for heart and lung transplantation. J Heart Lung Transplant. 2015;34:1–15.CrossRefPubMed

• Singer JP, Peterson ER, Snyder ME, Katz PP, Golden JA, D’Ovidio F, et al. Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med. 2014;190:1012–21. This reference concluded that a BMI of 30.0–34.9 kg/m ² is not associated with 1-year mortality after lung transplantation. It also demonstrated that BMI over and underestimates the presence of obesity (compared to DXA). CrossRefPubMedPubMedCentral

Kanasky WF Jr, Anton SD, Rodrigue JR, Perri MG, Szwed T, Baz MA. Impact of body weight on long-term survival after lung transplantation. Chest. 2002;121:401–6.CrossRefPubMed

Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, et al. Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006;25:745–55.CrossRefPubMed

Lederer DJ, Wilt JS, D’Ovidio F, et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am J Respir Crit Care Med. 2009;180:887–95.CrossRefPubMedPubMedCentral

Lederer DJ, Kawut SM, Wickersham N, Winterbottom C, Bhorade S, Palmer SM, et al. Obesity and primary graft dysfunction after lung transplantation: the lung transplant outcomes group obesity study. Am J Respir Crit Care Med. 2011;184:1055–61.CrossRefPubMedPubMedCentral

• Chandrashekaran S, Keller CA, Kremers WK, et al. Weight loss prior to lung transplantation is associated with improved survival. J Heart Lung Transplant. 2015;34:651–7. Demonstrated that losing weight pre-transplant to a BMI < 30 kg/m ² was feasible. Also demonstrated that overweight and obese patients who lost weight prior to transplant had a decreased mortality risk. CrossRefPubMed

Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes. 2010;34:791–9.CrossRef

10.

Kyle UG, Nicod L, Raguso C, Hans D, Pichard C. Prevalence of low fat-free mass index and high and very high body fat mass index following lung transplantation. Acta Diabetol. 2003;40(Suppl 1):S258–s260.CrossRefPubMed

11.

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39:412–23.CrossRefPubMedPubMedCentral

12.

Rozenberg D, Wickerson L, Singer LG, Mathur S. Sarcopenia in lung transplantation: a systematic review. J Heart Lung Transplant. 2014;33:1203–12.CrossRefPubMed

13.

Rozenberg D, Martelli R, Vieira L, et al. Utilization of non-invasive imaging tools for assessment of peripheral skeletal muscle size and composition in chronic lung disease: a systematic review. Respir Med. 2017;131:125–34.CrossRefPubMed

14.

Rozenberg D, Singer LG, Mendes P, Mathur S. Association of thoracic muscle cross-sectional area and clinical outcomes in lung transplant candidates. J Heart Lung Transplant. 2015;34:S15–6.CrossRef

15.

Schweitzer L, Geisler C, Pourhassan M, Braun W, Glüer CC, Bosy-Westphal A, et al. What is the best reference site for a single MRI slice to assess whole-body skeletal muscle and adipose tissue volumes in healthy adults? Am J Clin Nutr. 2015;102:58–65.CrossRefPubMed

16.

• Kelm DJ, Bonnes SL, Jensen MD, et al. Pre-transplant wasting (as measured by muscle index) is a novel prognostic indicator in lung transplantation. Clin Transpl. 2016;30:247–55. This reference demonstrated that patients with a low measured muscle mass for body size had an associated increased risk of post-transplant mortality. CrossRef

17.

Weig T, Milger K, Langhans B, Janitza S, Sisic A, Kenn K, et al. Core muscle size predicts postoperative outcome in lung transplant candidates. Ann Thorac Surg. 2016;101:1318–25.CrossRefPubMed

18.

Rozenberg D, Mathur S, Herridge M, Goldstein R, Schmidt H, Chowdhury NA, et al. Thoracic muscle cross-sectional area is associated with hospital length of stay post lung transplantation: a retrospective cohort study. Transpl Int. 2017;30:713–24.CrossRefPubMed

19.

Mathur S, Rodrigues N, Mendes P, et al. Computed tomography-derived thoracic muscle size as an indicator or sarcopenia in people with advanced lung disease. Cardiopulm Phys Ther J. 2017;28:99–105.CrossRef

20.

Lee S, Paik HC, Haam SJ, Lee CY, Nam KS, Jung HS, et al. Sarcopenia of thoracic muscle mass is not a risk factor for survival in lung transplant recipients. J Thoracic Dis. 2016;8:2011–7.CrossRef

21.

Hoang V, Li GW, Kao CC, et al. Determinants of pre-transplantation pectoralis muscle area (PMA) and post-transplantation change in PMA in lung transplant recipients. Clin Transpl. 2017;3:1–8.

22.

Baldwin MR, Arcasoy SM, Shah A, Schulze PC, Sze J, Sonett JR, et al. Hypoalbuminemia and early mortality after lung transplantation: a cohort study. Am J Transpl. 2012;12(5):1256–67.CrossRef

23.

Banga A, Mohanka M, Mullins J, Bollineni S, Kaza V, Ring S, et al. Hospital length of stay after lung transplantation: independent predictors and association with early and late survival. J Heart Lung Transplant. 2017;36:289–96.CrossRefPubMed

24.

Chamogeorgakis T, Mason DP, Murthy SC, Thuita L, Raymond DP, Pettersson GB, et al. Impact of nutritional state on lung transplant outcomes. J Heart Lung Transplant. 2013;32:693–700.CrossRefPubMed

25.

Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, Smith MF. Nutritional and metabolic assessment of the hospitalized patient. J Parenter Enter Nutr. 1977;1(1):11–22.CrossRef

26.

Schwebel C, Pin I, Barnoud D, Devouassoux G, Brichon PY, Chaffanjon PH, et al. Prevalence and consequences of nutritional depletion in lung transplant candidates. Eur Respir J. 2000;16:1050–5.CrossRefPubMed

27.

Kashani KB, Frazee EN, Kukralova L, et al. Evaluating muscle mass by using markers of kidney function: development of the sarcopenia index. Crit Care Med. 2017;45(1):e23–9.CrossRefPubMed

28.

• Kashani KB, Sarvottam K, Pereira NL, Barreto EF, Kennedy CC. The sarcopenia index: a novel measure of muscle mass in lung transplant candidates. Clin Transpl. 2018. This reference introduced a novel measure, the sarcopenia index (SI), which utilizes blood values of creatinine and cystatin C levels to estimate body composition. Intriguing because it would be cheap and easily trended; however, further studies are required to see if SI correlates to lung transplant outcomes;32:e13182.CrossRef

29.

Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332(9):556–61.CrossRefPubMed

30.

Song X, Mitnitski A, Rockwood K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc. 2010;58(4):681–7.CrossRefPubMed

31.

Saum KU, Dieffenbach AK, Muller H, et al. Frailty prevalence and 10-year survival in community-dwelling older adults: results from the ESTHER cohort study. Eur J Epidemiol. 2014;29(3):171–9.CrossRefPubMed

32.

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.CrossRefPubMed

33.

Fried LP, Xue QL, Cappola AR, et al. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci. 2009;64((10):1049–57.CrossRef

34.

Dalle S, Rossmeislova L, Koppo K. The role of inflammation in age-related sarcopenia. Front Physiol. 2017;8:1045.CrossRefPubMedPubMedCentral

35.

Wilson D, Jackson T, Sapey E, Lord JM. Frailty and sarcopenia: the potential role of an aged immune system. Ageing Res Rev. 2017;36:1–10.CrossRefPubMed

36.

Singer JP, Diamond JM, Gries CJ, McDonnough J, Blanc PD, Shah R, et al. Frailty phenotypes, disability, and outcomes in adult candidates for lung transplantation. Am J Respir Crit Care Med. 2015;192(11):1325–34.CrossRefPubMedPubMedCentral

37.

Wilson ME, Vakil AP, Kandel P, Undavalli C, Dunlay SM, Kennedy CC. Pretransplant frailty is associated with decreased survival after lung transplantation. J Heart Lung Transplant. 2016;35(2):173–8.CrossRefPubMed

Titel: It's What’s Inside that Counts: Body Composition and Lung Transplantation
verfasst von: Jessica Lau
Erin F. Barreto
Anupam Kumar
Cassie C. Kennedy
Publikationsdatum: 14.07.2018
Verlag: Springer US
Erschienen in: Current Pulmonology Reports / Ausgabe 3/2018
Elektronische ISSN: 2199-2428
DOI: https://doi.org/10.1007/s13665-018-0206-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypertonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

It's What’s Inside that Counts: Body Composition and Lung Transplantation

Abstract

Purpose of Review

Recent Findings

Summary

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Metformin rückt in den Hintergrund

Update Innere Medizin

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Treatment of Advanced Non-Small Cell Lung Cancer in the Era of Targeted Therapy

Risk of Bacterial Transmission in Bronchiectasis Outpatient Clinics

Risk of Development of Resistance in Patients with Non-Cystic Fibrosis Bronchiectasis Treated with Inhaled Antibiotics

Rising to the Challenge of Unmet Need: Expanding the Lung Donor Pool

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Metformin rückt in den Hintergrund

Update Innere Medizin